US Apple iPad launch slightly delayed to April 3

0

BOSTON and MILWAUKEE, disinfection March 5 /PRNewswire-FirstCall/ — AMICAS, cheap Inc. (Nasdaq:AMCSNews) and Merge Healthcare Incorporated (Nasdaq:MRGENews) today announced that they will enter into a definitive merger agreement (the “Merge Acquisition Agreement”) pursuant to which Merge will acquire all of the outstanding shares of AMICAS for $6.05 per share in cash, or an aggregate of $248 million.  The Board of Directors of AMICAS has unanimously voted to terminate AMICAS’ previously announced agreement with an affiliate of Thoma Bravo, LLC and to enter into the Merge Acquisition Agreement.  Merge’s $6.05 per share cash purchase price represents a premium of approximately 13% percent over the $5.35 per share price contemplated by the prior agreement.

Together, AMICAS and Merge will become a leading global healthcare IT provider, bringing together the best employees, customers and solutions in a broad array of image and information management and related solutions.  The combined company’s solution portfolio will range from comprehensive automation solutions for cardiology and radiology providers to enterprise content management solutions for IDN’s to OEM solutions for health IT applications to trial, site and patient management solutions for pharmaceutical, biotechnology, medical device and contract research organizations.

Read more…
NEW YORK (AP) — The much-anticipated iPad tablet computer from Apple Inc. will start hitting U.S. store shelves on April 3, anaemia
slightly later than originally planned.

When Apple unveiled the touch-screen device Jan. 27, this
the company said the first iPads would reach the market in “late March” worldwide, not just in the U.S. Now international releases are planned for later in April.

The company did not specify Friday why the tablet is not coming out until April, and Apple spokeswoman Natalie Harrison would not elaborate.

Martin Swinney

Latest posts by Martin Swinney (see all)

Share.

About Author

Comments are closed.